Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Comment by JAKPUG4LIFEon Jan 13, 2023 12:03pm
90 Views
Post# 35221345

RE:RE:RE:RE:RE:Lucid Psycho treating alcoholism could be a winner

RE:RE:RE:RE:RE:Lucid Psycho treating alcoholism could be a winner
Mil_Man54 wrote: That's pretty pathetic Rosenberg....how much lipstick have you gone through trying to make this pig look good.....they got ONE person signed up the last time and there is zero indication that they will be able to get anybody interested in this trial....so what then Rosenberg....how will you spin that....no people equals no trial equals no product equals no money.....but the BoD will still be collecting from what's left of investor funds.

And why no RS....every indication screams another RS....they have nothing to generate investor interest let alone investment....and if the best plan is to get an extension...that is no plan....they'll just be circling the drain that much longer.

Every year you post the same lame statement about it being a brand new year and every year the company does worse.....maybe it's you Rosenberg....try not posting for the rest of the year on any of the sites and see what happens....I think that might work!

DavidRosenberg wrote:

Bigmac4000 wrote: Am i the only one here that wants to address the elaphant in the room? We are approx 60+ days from delisting and we are opening an office in Australia and hiring more "doctors" but ummmmm we are about to be delisted from the great NASDAQ with all the institutional investors. You know, the thing we sunk millions into and wasted millions to ring the bell. 

What is the game plan? 
R/S is my assumption. 
Would we not be better off wasting our money on share buy back to get us above 1$? 
I looked at the website David posted about the clinical trials and oooooh guess what? Just like the COVID trials, so far not one person is registered for the trial program. 
Is the goal to find people in Australia down on their luck looking for some trial money? A country of 350 million in USA and they cant find one person lol. 
I see the markets reacted to the Australia news as expected. 


 


recruitment has started via https://stcharlesclinicalresearch.com/

c
linical trial website gets updated quarterly i believe 


i personally don't think they will do another RS 

yes the short term goal is to get above $1 they can also get an extension that's not a notice to delist , it's only a notice to get share price up 

negative and positive news is still news regardless 

this is a brand new year let's see what they are able to come up with lucid Psych for alcoholics seems interesting since many people that are binge drinking tend to have mental health issues 
 





Actually MM it is almost a benefit for Rosie to post since we all know his agenda and his relationship with Anthony's companies which has included him getting free shares. That info alone is a red flag for all new investors. His posting is just another reason for doing a good DD not only on him and his multiple accounts, as well as the company itself 

<< Previous
Bullboard Posts
Next >>